within Pharmacolibrary.Drugs.ATC.S;

model S01AA31
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00011500000000000002,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0148,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01AA31</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cefmenoxime is a third-generation cephalosporin antibiotic used for treatment of bacterial infections including ocular infections. It is primarily active against a variety of Gram-negative and some Gram-positive bacteria. As an ophthalmic preparation (ATC S01AA31), it is used for treating external ocular infections. While it has seen use in several countries, its current approval status varies and may be limited in some regions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult healthy volunteers after a single intravenous dose.</p><h4>References</h4><ol><li><p>Granneman, GR, et al., &amp; Sonders, RC (1982). Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects. <i>Antimicrobial agents and chemotherapy</i> 21(1) 141–145. DOI:<a href=&quot;https://doi.org/10.1128/AAC.21.1.141&quot;>10.1128/AAC.21.1.141</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6282203/&quot;>https://pubmed.ncbi.nlm.nih.gov/6282203</a></p></li><li><p>Sennello, LT, et al., &amp; Sonders, RC (1983). Effect of probenecid on the pharmacokinetics of cefmenoxime. <i>Antimicrobial agents and chemotherapy</i> 23(6) 803–807. DOI:<a href=&quot;https://doi.org/10.1128/AAC.23.6.803&quot;>10.1128/AAC.23.6.803</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6311084/&quot;>https://pubmed.ncbi.nlm.nih.gov/6311084</a></p></li><li><p>Veyssier, P, et al., &amp; Fourtillan, JB (1986). [Pharmacokinetics of cefmenoxime in the aged subject (60 to 90 years of age) after an intravenous injection of 1 g]. <i>Pathologie-biologie</i> 34(10) 1081–1083. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3547264/&quot;>https://pubmed.ncbi.nlm.nih.gov/3547264</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01AA31;
